The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Myc and the cell cycle
Abstract
Ectopic expression of the c-Myc oncoprotein prevents cell cycle arrest in response to growth-inhibitory signals, differentiation stimuli, or mitogen withdrawal. Moreover, Myc activation in quiescent cells is sufficient to induce cell cycle entry in the absence of growth factors. Thus, Myc transduces a potent mitogenic stimulus but, concomitantly, induces apoptosis in the absence of survival factors. We review here recent progress in our understanding of the molecular mechanisms linking Myc activity to cell cycle control. Myc is a positive regulator of G1-specific cyclin-dependent kinases (CDKs) and, in particular, of cyclin E/CDK2 complexes. Cyclin D/CDK4 and CDK6 may conceivably also be activated by Myc, but the circumstances in which this occurs remain to be explored. Myc acts via at least three distinct pathways which can enhance CDK function: (1) functional inactivation of the CDK inhibitor p27Kip1 and probably also of p21Cip1 and p57Kip2, (2) induction of the CDK-activating phosphatase Cdc25A and (3) - in an ill understood and most likely indirect way - deregulation of cyclin E expression. Constitutive expression of either Myc or cyclin E can prevent growth arrest by p16INK4a (an inhibitor of cyclin D/CDK4, but not of cyclin E/CDK2). In cells, p16INK4a inhibits phosphorylation, and thus induces activation of the Retinoblastoma-family proteins (pRb, p107 and p130). Surprisingly, this effect of p16 is not altered in the presence of Myc or cyclin E. Thus, Myc and cyclin E/CDK2 activity unlink activation of p16 and pRb from growth arrest. Finally, Myc may itself be a functional target of cyclin D/CDK4 through its direct interaction with p107. We discuss how the effects of Myc on cell cycle control may relate to its oncogenic activity, and in particular to its ability to cooperate with activated Ras oncoproteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., & Rolfe, M. (1995) · Science · doi:10.1126/science.7624798 · Cited by 1,817
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Activating Smoothened mutations in sporadic basal-cell carcinoma
Xie, J., Murone, M., Luoh, S.-M., Ryan, A., Gu, Q., Zhang, C., Bonifas, J. M., Lam, C.-W., Hynes, M., Goddard, A., et al. (1998) · Nature · doi:10.1038/34201 · Cited by 1,334
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,251
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Human Cyclin E, a Nuclear Protein Essential for the G1-to-S Phase Transition
Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., & Pagano, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2612 · Cited by 1,148
Cellular Oncogenes and Multistep Carcinogenesis
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Science · doi:10.1126/science.6356358 · Cited by 1,127
Sherr, C. J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89005-2 · Cited by 980
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir, I., Polyak, K., Iavarone, A., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.15.1831 · Cited by 962
DeGregori, J., Kowalik, T., & Nevins, J. R. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4215 · Cited by 919
Cyclin E-CDK2 is a regulator of p27Kip1.
Sheaff, R. J., Groudine, M., Gordon, M., Roberts, J. M., & Clurman, B. E. (1997) · Genes & Development · doi:10.1101/gad.11.11.1464 · Cited by 911
Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., & Roberts, J. M. (1997) · Nature Medicine · doi:10.1038/nm0297-222 · Cited by 901
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899
Askew, D. S., Ashmun, R. A., Simmons, B. C., & Cleveland, J. L. (1991) · PubMed · Cited by 867
Catzavelos, C., Bhattacharya, N., Ung, Y. C., Wilson, J. A., Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Morava-Protzner, I., Kapusta, L., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-227 · Cited by 823
Marcu, K. B., Bossone, S. A., & Patel, A. J. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.004113 · Cited by 802
Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R., & Leder, P. (1987) · Cell · doi:10.1016/0092-8674(87)90449-1 · Cited by 792
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
The ornithine decarboxylase gene is a transcriptional target of c-Myc.
Bello-Fernandez, C., Packham, G., & Cleveland, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7804 · Cited by 777
Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites
Zervos, A. S., Gyuris, J., & Brent, R. (1993) · Cell · doi:10.1016/0092-8674(93)90662-a · Cited by 775
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Zhang, P., Liégeois, N. J., Wong, C., Finegold, M., Hou, H., Thompson, J. C., Silverman, A., Harper, J. W., DePinho, R. A., & Elledge, S. J. (1997) · Nature · doi:10.1038/387151a0 · Cited by 749
c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.
Harrington, E. A., Bennett, M. R., Fanidi, A., & Evan, G. I. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06630.x · Cited by 742
Mediation of c-Myc-Induced Apoptosis by p53
Hermeking, H., & Eick, D. (1994) · Science · doi:10.1126/science.8091232 · Cited by 739
Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
Ayer, D. E., Kretzner, L., & Eisenman, R. N. (1993) · Cell · doi:10.1016/0092-8674(93)90661-9 · Cited by 703
Cdc25 cell-cycle phosphatase as a target of c-myc
Galaktionov, K., Chen, X., & Beach, D. (1996) · Nature · doi:10.1038/382511a0 · Cited by 690
Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1
Vlach, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5334 · Cited by 688
Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5598 · Cited by 639
Regulation of the cyclin E gene by transcription factor E2F1.
Ohtani, K., DeGregori, J., & Nevins, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12146 · Cited by 635
Ornithine decarboxylase activity is critical for cell transformation
Auvinen, M., Paasinen, A., Andersson, L. C., & Hölttä, E. (1992) · Nature · doi:10.1038/360355a0 · Cited by 629
Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Münger, K., Howley, P. M., & Moses, H. L. (1990) · Cell · doi:10.1016/0092-8674(90)90188-k · Cited by 609
The MYC protein activates transcription of the alpha-prothymosin gene.
Eilers, M., Schirm, S., & Bishop, J. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07929.x · Cited by 578
Oncogenic activity of the c-Myc protein requires dimerization with Max
Amati, B., Brooks, M. W., Levy, N., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · Cell · doi:10.1016/0092-8674(93)90663-b · Cited by 560
Self-citationWagner, A. J., Kokontis, J. M., & Hay, N. (1994) · Genes & Development · doi:10.1101/gad.8.23.2817 · Cited by 539
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E. (1995) · Nature · doi:10.1038/375506a0 · Cited by 516
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.
Zhu, L., van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N., & Harlow, E. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1111 · Cited by 514
CDC25 Phosphatases as Potential Human Oncogenes
Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., & Beach, D. (1995) · Science · doi:10.1126/science.7667636 · Cited by 504
Helin, K., Wu, C. L., Fattaey, A. R., Lees, J. A., Dynlacht, B. D., Ngwu, C., & Harlow, E. (1993) · Genes & Development · doi:10.1101/gad.7.10.1850 · Cited by 496
Hoffmann, I., Draetta, G., & Karsenti, E. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06750.x · Cited by 494
Yan, Y., Frisén, J., Lee, M. H., Massagué, J., & Barbacid, M. (1997) · Genes & Development · doi:10.1101/gad.11.8.973 · Cited by 493
Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491
Zhan, Q., Lord, K. A., Alamo, I., Hollander, M. C., Carrier, F., Ron, D., Kohn, K. W., Hoffman, B., Liebermann, D. A., & Fornace, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2361 · Cited by 482
Different Roles for Cyclins D1 and E in Regulation of the G1-to-S Transition
Resnitzky, D., & Reed, S. I. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3463 · Cited by 472
(1993) · PubMed · Cited by 469
Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F
Leone, G., DeGregori, J., Sears, R., Jakoi, L., & Nevins, J. R. (1997) · Nature · doi:10.1038/387422a0 · Cited by 468
High-Intensity Raf Signal Causes Cell Cycle Arrest Mediated by p21 Cip1
Sewing, A., Wiseman, B., Lloyd, A. C., & Land, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5588 · Cited by 462
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max
Amati, B., Dalton, S., Brooks, M. W., Littlewood, T. D., Evan, G. I., & Land, H. (1992) · Nature · doi:10.1038/359423a0 · Cited by 460
Self-citationChimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells
Eilers, M., Picard, D., Yamamoto, K. R., & Bishop, J. M. (1989) · Nature · doi:10.1038/340066a0 · Cited by 458
Myc and Max proteins possess distinct transcriptional activities
Kretzner, L., Blackwood, E. M., & Eisenman, R. N. (1992) · Nature · doi:10.1038/359426a0 · Cited by 453
Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.
Mateyak, M. K., Obaya, Á. J., Adachi, S., & Sedivy, J. M. (1997) · PubMed · Cited by 443
Bodrug, S. E., Warner, B. J., Bath, M. L., Lindeman, G. J., Harris, A. W., & Adams, J. M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06488.x · Cited by 441
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene
Newbold, R. F., & Overell, R. W. (1983) · Nature · doi:10.1038/304648a0 · Cited by 436
Growth suppression by p16ink4 requires functional retinoblastoma protein
Medema, R. H., Herrera, R. E., Lam, F., & Weinberg, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6289 · Cited by 433
Hurford, R. K., Cobrinik, D., Lee, M. H., & Dyson, N. (1997) · Genes & Development · doi:10.1101/gad.11.11.1447 · Cited by 431
Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.
Lovec, H., Grzeschiczek, A., Kowalski, M. B., & Möröy, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06655.x · Cited by 410
Aktas, H., Cai, H., & Cooper, G. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3850 · Cited by 410
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J. W., & DePinho, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.21.2822 · Cited by 402
Cdk inhibitors in development and cancer
Wade Harper, J., & Elledge, S. J. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)90011-8 · Cited by 399
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max.
Amati, B., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06202.x · Cited by 385
Self-citationRegulation of cyclin E transcription by E2Fs and retinoblastoma protein.
Geng, Y., Eaton, E. N., Picón, M., Roberts, J. M., Lundberg, A. S., Gifford, A. M., Sardet, C., & Weinberg, R. A. (1996) · PubMed · Cited by 378
Cyclin E-induced S phase without activation of the pRb/E2F pathway.
Lukas, J., Herzinger, T., Hansen, K., Moroni, M. C., Resnitzky, D., Helin, K., Reed, S. I., & Bartek, J. (1997) · Genes & Development · doi:10.1101/gad.11.11.1479 · Cited by 378
lavarone, A., & Massagué, J. (1997) · Nature · doi:10.1038/387417a0 · Cited by 377
Inhibition of Ras-Induced Proliferation and Cellular Transformation by p16 INK4
Serrano, M., Gómez-Lahoz, E., DePinho, R. A., Beach, D., & Bar-Sagi, D. (1995) · Science · doi:10.1126/science.7809631 · Cited by 373
Lukas, J., Bartkova, J., Rohde, M., Strauss, M., & Bartek, J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2600 · Cited by 366
An alternative pathway for gene regulation by Myc
Peukert, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5672 · Cited by 364
Amati, B., & Land, H. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90098-1 · Cited by 362
Self-citationRas signalling linked to the cell-cycle machinery by the retinoblastoma protein
Peeper, D. S., Upton, T. M., Ladha, M. H., Neuman, E., Zalvide, J., Bernards, R., DeCaprio, J. A., & Ewen, M. E. (1997) · Nature · doi:10.1038/386177a0 · Cited by 357
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
Thompson, T. C., Southgate, J., Kitchener, G., & Land, H. (1989) · Cell · doi:10.1016/0092-8674(89)90625-9 · Cited by 352
What is the restriction point?
Zetterberg, A., Larsson, O., & Wiman, K. G. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80067-0 · Cited by 351
Cyclin E, a Potential Prognostic Marker in Breast Cancer.
Keyomarsi, K. (1997) · doi:10.21236/ada341275 · Cited by 344
Enhanced proliferative potential in culture of cells from p53-deficient mice.
Tsukada, T., Tomooka, Y., Takai, S., Ueda, Y., Nishikawa, S.-I., Yagi, T., Tokunaga, T., Takeda, N., Suda, Y., & Abe, S. (1993) · PubMed · Cited by 341
Hurlin, P. J., Quéva, C., Koskinen, P. J., Steingrímsson, E., Ayer, D. E., Copeland, N. G., Jenkins, N. A., & Eisenman, R. N. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00252.x · Cited by 339
Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product
Cavanaugh, A. H., Hempel, W. M., Taylor, L. J., Rogalsky, V., Todorov, G., & Rothblum, L. I. (1995) · Nature · doi:10.1038/374177a0 · Cited by 334
Reynisdóttir, I., & Massagué, J. (1997) · Genes & Development · doi:10.1101/gad.11.4.492 · Cited by 333
Differential modulation of cyclin gene expression by MYC.
Jansen-Dürr, P., Meichle, A., Steiner, P., Pagano, M., Finke, K., Botz, J., Wessbecher, J., Draetta, G., & Eilers, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3685 · Cited by 314
Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
Vlach, J., Hennecke, S., Alevizopoulos, K., Conti, D., & Amati, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01050.x · Cited by 313
Self-citationMyc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src
Barone, M. V., & Courtneidge, S. A. (1995) · Nature · doi:10.1038/378509a0 · Cited by 309
Herrera, R. E., Sah, V. P., Williams, B. O., Mäkelä, T. P., Weinberg, R. A., & Jacks, T. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2402 · Cited by 304
Lukas, J., Petersen, B. O., Holm, K., Bartek, J., & Helin, K. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1047 · Cited by 303
A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
Ayer, D. E., & Eisenman, R. N. (1993) · Genes & Development · doi:10.1101/gad.7.11.2110 · Cited by 291
Rosenwald, I. B., Lazaris-Karatzas, A., Sonenberg, N., & Schmidt, E. V. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7358 · Cited by 287
Grandori, C. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01025-6 · Cited by 285
E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor.
Hiebert, S. W., Lipp, M., & Nevins, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3594 · Cited by 274
Lukas, J., Müller, H., Bartkova, J., Spitkovsky, D., Kjerulff, A. A., Jansen-Dürr, P., Strauss, M., & Bartek, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.3.625 · Cited by 269
Krek, W., Livingston, D. M., & Shirodkar, S. (1993) · Science · doi:10.1126/science.8248803 · Cited by 267
Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts.
Land, H., Chen, A. C., Morgenstern, J. P., Parada, L. F., & Weinberg, R. A. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.6.1917 · Cited by 266
Bandara, L. R., Buck, V. M., Zamanian, M., Johnston, L. H., & La Thangue, N. B. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06116.x · Cited by 257
Rosenwald, I. B., Rhoads, D. B., Callanan, L. D., Isselbacher, K. J., & Schmidt, E. V. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6175 · Cited by 255
Control of cell proliferation by Myc
Bouchard, C., Staller, P., & Eilers, M. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01251-3 · Cited by 253
The transcription factor E2F is required for S phase during Drosophila embryogenesis.
Duronio, R. J., O'Farrell, P. H., Xie, J. E., Brook, A., & Dyson, N. (1995) · Genes & Development · doi:10.1101/gad.9.12.1445 · Cited by 253
Repression of cyclin D1: a novel function of MYC.
Philipp, A., Schneider, A., Väsrik, I., Finke, K., Xiong, Y., Beach, D., Alitalo, K., & Eilers, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.4032 · Cited by 251
The Retinoblastoma Protein: A Master Regulator of Cell Cycle, Differentiation and Apoptosis
Herwig, S., & Strauss, M. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00581.x · Cited by 250
Oncogene-induced liver neoplasia in transgenic mice.
Sandgren, E. P., Quaife, C. J., Pinkert, C. A., Palmiter, R. D., & Brinster, R. L. (1989) · PubMed · Cited by 248
Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.
Beijersbergen, R. L., Carlée, L., Kerkhoven, R. M., & Bernards, R. (1995) · Genes & Development · doi:10.1101/gad.9.11.1340 · Cited by 248
Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.
Steiner, P., Philipp, A., Lukas, J., Godden-Kent, D., Pagano, M., Mittnacht, S., Bartek, J., & Eilers, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00163.x · Cited by 246
Hurlin, P. J., Quéva, C., & Eisenman, R. N. (1997) · Genes & Development · doi:10.1101/gad.11.1.44 · Cited by 245
Thalmeier, K., Synovzik, H., Mertz, R., Winnacker, E. L., & Lipp, M. (1989) · Genes & Development · doi:10.1101/gad.3.4.527 · Cited by 245
Packham, G., & Cleveland, J. L. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)00015-t · Cited by 245
Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis.
Packham, G., & Cleveland, J. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5741 · Cited by 245
Cell Cycle Regulation of the Murine Cyclin E Gene Depends on an E2F Binding Site in the Promoter
Botz, J., Zerfass-Thome, K., Spitkovsky, D., Delius, H., Vogt, B., Eilers, M., Hatzigeorgiou, A., & Jansen-Dürr, P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3401 · Cited by 245
Induction of Mammary Gland Hyperplasia and Carcinomas in Transgenic Mice Expressing Human Cyclin E
Bortner, D. M., & Rosenberg, M. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.453 · Cited by 245
Mudryj, M., Hiebert, S. W., & Nevins, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07387.x · Cited by 244
Direct role for Myc in transcription initiation mediated by interactions with TFII-I
Roy, A. L., Carruthers, C., Gutjahr, T., & Roeder, R. G. (1993) · Nature · doi:10.1038/365359a0 · Cited by 244
Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos, T. J., Kiyokawa, H., Yan, J. S., Rubin, M. S., Giordano, A., DeBlasio, A., Bottega, S., Wong, B., Mendelsohn, J. M., & Koff, A. (1996) · PubMed · Cited by 239
Jones, R. M., Branda, J., Johnston, K. A., Polymenis, M., Gadd, M., Rustgi, A., Callanan, L., & Schmidt, E. V. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4754 · Cited by 237
Binding and Suppression of the Myc Transcriptional Activation Domain by p107
Gu, W., Bhatia, K., Magrath, L. T., Dang, C. V., & Dalla-Favera, R. (1994) · Science · doi:10.1126/science.8146655 · Cited by 235
Poon, R. Y., Toyoshima, H., & Hunter, T. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.9.1197 · Cited by 234
E2F and Cell Proliferation: A World Turned Upside Down
Weinberg, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81244-1 · Cited by 233
Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation.
Galaktionov, K., Jessus, C., & Beach, D. (1995) · Genes & Development · doi:10.1101/gad.9.9.1046 · Cited by 232
Shibuya, H., Yoneyama, M., Ninomiya-Tsuji, J., Matsumoto, K., & Taniguchi, T. (1992) · Cell · doi:10.1016/0092-8674(92)90533-i · Cited by 231
Pérez-Roger, I., Solomon, D. L., Sewing, A., & Land, H. (1997) · Oncogene · doi:10.1038/sj.onc.1201197 · Cited by 230
Duronio, R. J., & O'Farrell, P. H. (1995) · Genes & Development · doi:10.1101/gad.9.12.1456 · Cited by 228
Daksis, J. I., Lu, R. Y., Facchini, L. M., Marhin, W. W., & Penn, L. Z. (1994) · PubMed · Cited by 227
Cooperating oncogenes converge to regulate cyclin/cdk complexes.
Lloyd, A. C., Obermüller, F., Staddon, S., Barth, C. F., McMahon, M., & Land, H. (1997) · Genes & Development · doi:10.1101/gad.11.5.663 · Cited by 224
Quelle, D. E., Cheng, M., Ashmun, R. A., & Sherr, C. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.669 · Cited by 220
Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression.
Moshier, J. A., Dosescu, J., Skunca, M., & Luk, G. D. (1993) · PubMed · Cited by 218
Ridley, A. J., Paterson, H. F., Noble, M., & Land, H. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02990.x · Cited by 216
Sears, R., Ohtani, K., & Nevins, J. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5227 · Cited by 214
DeGregori, J., Leone, G., Ohtani, K., Miron, A., & Nevins, J. R. (1995) · Genes & Development · doi:10.1101/gad.9.23.2873 · Cited by 210
Repression of RNA polymerase III transcription by the retinoblastoma protein
White, R. J., Trouche, D., Martin, K., Jackson, S. P., & Kouzarides, T. (1996) · Nature · doi:10.1038/382088a0 · Cited by 204
Alevizopoulos, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5322 · Cited by 203
Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis.
Bártková, J., Lukáš, J., von Strauss, M., & Bártek, J. (1995) · PubMed · Cited by 202
Kawada, M., Yamagoe, S., Murakami, Y., Suzuki, K., Mizuno, S., & Uehara, Y. (1997) · Oncogene · doi:10.1038/sj.onc.1201228 · Cited by 196
The Transcription Factor E2F-1 Is a Downstream Target of RB Action
Qin, X.-Q., Livingston, D. M., Ewen, M., Sellers, W. R., Arany, Z., & Kaelin, W. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.742 · Cited by 188
Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins
Beijersbergen, R. L., & Bernards, R. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00002-9 · Cited by 176
Vairapandi, M., Balliet, A. G., Fornace, A. J., Hoffman‐Liebermann, B., & Liebermann, D. A. (1996) · PubMed · Cited by 175
Mechanism of Repression of RNA Polymerase I Transcription by the Retinoblastoma Protein
Voit, R., Schäfer, K., & Grummt, I. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4230 · Cited by 172
Müller, D., Bouchard, C., Rudolph, B., Steiner, P., Stuckmann, I., Saffrich, R., Ansorge, W., Huttner, W., & Eilers, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201440 · Cited by 167
Franza, B. R., Maruyama, K., Garrels, J. I., & Ruley, H. E. (1986) · Cell · doi:10.1016/0092-8674(86)90462-9 · Cited by 166
Polunovsky, V. A., Rosenwald, I. B., Tan, A. T., White, J., Chiang, L., Sonenberg, N., & Bitterman, P. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6573 · Cited by 165
Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo.
Downs, K. M., Martin, G. R., & Bishop, J. M. (1989) · Genes & Development · doi:10.1101/gad.3.6.860 · Cited by 165
Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling
Roussel, M. F., Cleveland, J. L., Shurtleff, S. A., & Sherr, C. J. (1991) · Nature · doi:10.1038/353361a0 · Cited by 164
Unrestricted cell cycling and cancer
Strauss, M., Lukas, J., & Bartek, J. (1995) · Nature Medicine · doi:10.1038/nm1295-1245 · Cited by 158
Regulation of cell cycle duration by c-myc levels.
Karn, J., Watson, J. V., Lowe, A. D., Green, S. M., & Vedeckis, W. V. (1989) · PubMed · Cited by 152
Myc represses the growth arrest gene gadd45
Marhin, W. W., Chen, S., Facchini, L. M., Fornace, A. J., & Penn, L. Z. (1997) · Oncogene · doi:10.1038/sj.onc.1201138 · Cited by 152
Transcriptional regulation during the mammalian cell cycle
Müller, R. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89039-3 · Cited by 149
Langer, S. J., Bortner, D. M., Roussel, M. F., Sherr, C. J., & Ostrowski, M. C. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5355-5362.1992 · Cited by 146
Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130.
Mayol, X., Garriga, J., & Graña, X. (1995) · PubMed · Cited by 143
Beijersbergen, R. L., Hijmans, E. M., Zhu, L., & Bernards, R. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06725.x · Cited by 139
Hoang, A. T., Lutterbach, B. A., Lewis, B. C., Yano, T., Chou, T., Barrett, J. F., Raffeld, M. A., Hann, S., & Dang, C. V. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4031 · Cited by 139
Meroni, G., Reymond, A., Alcalay, M., Borsani, G., Tanigami, A., Tonlorenzi, R., Nigro, C. L., Messali, S., Zollo, M., Ledbetter, D. H., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2892 · Cited by 133
Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein
Mittnacht, S., Paterson, H., Olson, M. F., & Marshall, C. J. (1997) · Current Biology · doi:10.1016/s0960-9822(97)70094-0 · Cited by 131
Alexandrow, M. G., Kawabata, M., Aakre, M. E., & Moses, H. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3239 · Cited by 130
Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
Lukáš, J., Aagaard, L., Strauss, M., & Bártek, J. (1995) · PubMed · Cited by 127
Activation of cyclin‐dependent kinases by Myc mediates induction of cyclin A, but not apoptosis.
Rudolph, B., Saffrich, R., Zwicker, J., Henglein, B., Müller, R., Ansorge, W. J., & Eilers, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00669.x · Cited by 126
Gaubatz, S., Meichle, A., & Eilers, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3853 · Cited by 126
Cell cycle: Routine role for Ras
Downward, J. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00116-3 · Cited by 125
E2F-induced S phase requires cyclin E.Preprint
Duronio, R. J., Brook, A., Dyson, N. J., & O’Farrell, P. H. (1996) · Genes & Development · doi:10.1101/gad.10.19.2505 · Cited by 124
Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes
Metz, T. M., Harris, A. W., & Adams, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90049-7 · Cited by 123
G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts
Connell‐Crowley, L., Elledge, S. J., & Harper, J. W. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70021-1 · Cited by 122
Roussel, M. F., Jn, D., Jl, C., Ghysdael, J., & Hiebert, S. W. (1994) · PubMed · Cited by 121
Cyclin E, a redundant cyclin in breast cancer
Gray-Bablin, J., Zalvide, J. B., Fox, M., Knickerbocker, C. J., DeCaprio, J. A., & Keyomarsi, K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15215 · Cited by 119
Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.Preprint
Hofmann, F., & Livingston, D. M. (1996) · Genes & Development · doi:10.1101/gad.10.7.851 · Cited by 118
Berns, K., Hijmans, E. M., & Bernards, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201280 · Cited by 115
Graff, J. R., Boghaert, E. R., Benedetti, A. D., Tudor, D., Zimmer, C. C., Chan, S. K., & Zimmer, S. G. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600221 · Cited by 114
Rinker-Schaeffer, C. W., Graff, J. R., Benedetti, A. D., Zimmer, S. G., & Rhoads, R. E. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550525 · Cited by 114
The role of p21ras in receptor tyrosine kinase signalling
Pronk, G. J. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90010-8 · Cited by 113
p21CIP1 and Cdc25A: Competition between an Inhibitor and an Activator of Cyclin-Dependent Kinases
Saha, P., Eichbaum, Q. G., Silberman, E. D., Mayer, B. J., & Dutta, A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4338 · Cited by 112
Rescue of defective mitogenic signaling by D-type cyclins.
Roussel, M. F., Theodoras, A. M., Pagano, M., & Sherr, C. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6837 · Cited by 111
Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases.
Xiao, Z. J., Ginsberg, D., Ewen, M. E., & Livingston, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4633 · Cited by 107
The c-myc oncogene in tumor progression.
Sj, G. (1993) · PubMed · Cited by 107
Zou, X., Rudchenko, S., Wong, K., & Calame, K. L. (1997) · Genes & Development · doi:10.1101/gad.11.5.654 · Cited by 106
Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer.
Gao, X., Chen, Y. Q., Wu, N., Grignon, D. J., Sakr, W., Porter, A. T., & Honn, K. V. (1995) · PubMed · Cited by 106
Dobrowolski, S., Harter, M. L., & Stacey, D. W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5441-5449.1994 · Cited by 105
Leng, X., Connell‐Crowley, L., Goodrich, D. W., & Harper, J. W. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00301-0 · Cited by 105
Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein
Larminie, C. G. C., Cairns, C. A., Mital, R., Martin, K., Kouzarides, T., Jackson, S. P., & White, R. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.2061 · Cited by 102
Oswald, F., Lovec, H., Möröy, T., & Lipp, M. (1994) · PubMed · Cited by 101
Cyclin E, A Potential Prognostic Marker in Breast Cancer
Keyomarsi, K. (1998) · Defense Technical Information Center (DTIC) · doi:10.21236/ada368551 · Cited by 98
Contrasting roles for Myc and Mad proteins in cellular growth and differentiation.
Chin, L., Schreiber‐Agus, N., Pellicer, I., Chen, K., Lee, H.-W., Dudast, M., Cordon‐Cardo, C., & DePinho, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8488 · Cited by 93
Blyth, K., Terry, A., O'Hara, M., Ew, B., Campbell, M. E. M., Stewart, M., Donehower, L. A., Onions, D. E., Jc, N., & Cameron, E. R. (1995) · PubMed · Cited by 93
Regulatory Interactions Among E2Fs and Cell Cycle Control Proteins
Cobrinik, D. E. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-79910-5_2 · Cited by 89
Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis.
Hsu, B., Marín, M. C., El‐Naggar, A. K., Stephens, L. C., Brisbay, S. M., & McDonnell, T. J. (1995) · PubMed · Cited by 83
Elson, A., Deng, C., Campos-Torres, J., Donehower, L. A., & Leder, P. (1995) · PubMed · Cited by 79
Hermeking, H., Funk, J. O., Reichert, M., et al. (1995) · PubMed · Cited by 78
The role of eIF4 in cell proliferation.
Flynn, A., & Proud, C. G. (1996) · PubMed · Cited by 76
E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest
Mann, D. J., & Jones, N. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00515-8 · Cited by 76
Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor.
Thompson, J. S., Reese, K. J., DeBaun, M. R., et al. (1996) · PubMed · Cited by 74
Haas, K., Staller, P., Geisen, C., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201171 · Cited by 74
RNA Polymerase III Transcription Repressed by Rb through Its Interactions with TFIIIB and TFIIIC2
Chu, W.-M., Wang, Z., Roeder, R. G., & Schmid, C. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14755 · Cited by 73
Transforming collaborations between ras and nuclear oncogenes.
Ruley, H. E. (1990) · PubMed · Cited by 70
Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases
Pusch, O., BERNASCHEK, G., Eilers, M., & Hengstschläger, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201236 · Cited by 60
v-Abl Activates c- myc Transcription through the E2F Site
Wong, K., Zou, X., Merrell, K. T., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6535 · Cited by 57
Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
Kohl, N. E., & Ruley, H. E. (1987) · PubMed · Cited by 53
Cited by
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
A Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
Shaffer, A. L., Lin, K.-I., Kuo, T. C., Yu, X., Hurt, E. M., Rosenwald, A., Giltnane, J. M., Yang, L., Zhao, H., Calame, K., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00335-7 · Cited by 1,047
Metadata
- Authors
- Amati, B.
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 1998
- Volume
- 3
- Issue
- 4
- Pages
- d250-268
- ISSN
- 1093-4715 (ISSN-L)
- 1093-9946
- DOI
- 10.2741/a239
- OpenAlex
- W106241224
- Cited by
- 367
- References
- 212
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.